Mydecine Innovations Group Sponsors First Lab-Based Study of Established Microdosers at Macquarie University in Australia Psychedelics Investing
Medtronic Chairman and CEO Geoff Martha to Speak at J.P. Morgan Healthcare Conference Medical Device Investing
Bristol Myers Squibb to Present at J.P. Morgan's 39th Annual Virtual Healthcare Conference Biotech Investing
European Medicines Agency Validates Bristol Myers Squibb's Application for Opdivo as Adjuvant Treatment for Resected Esophageal or Gastroesophageal Junction Cancer Following Chemoradiotherapy Biotech Investing
European Medicines Agency Validates Bristol Myers Squibb's Application for Opdivo Combined with Chemotherapy as First-Line Treatment in Metastatic Gastric Cancer, Gastroesophageal Junction Cancer and Esophageal Adenocarcinoma Biotech Investing
US FDA Accepts Regulatory Submission from Pfizer and OPKO for Review of Somatrogon to Treat Pediatric Patients with Growth Hormone Deficiency Pharmaceutical Investing
